This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business class action lawsuit

Geron Corporation Securities Fraud Lawsuits

Analysis based on 48 articles · First reported Mar 13, 2025 · Last updated Apr 04, 2025

Sentiment
-70
Attention
4
Articles
48
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The market is negatively impacted by the alleged securities fraud by Geron Corporation, leading to a significant decline in its stock price. The ongoing class action lawsuits by firms like Levi & Korsinsky, The Gross Law Firm, and Robbins Geller Rudman & Dowd LLP create uncertainty for investors and highlight the importance of corporate transparency in the biotechnology sector.

Biotechnology Legal Services

Geron Corporation is facing multiple class action lawsuits for alleged securities fraud. Law firms including Levi & Korsinsky, The Gross Law Firm, and Robbins Geller Rudman & Dowd LLP are representing investors who suffered losses due to allegedly misleading statements made by Geron Corporation regarding the launch and growth potential of its drug, Rytello (imetelstat). The lawsuits claim that Geron Corporation minimized risks associated with Rytello's weekly monitoring requirement, seasonality, and existing competition, and that the drug lacked necessary market awareness. On February 26, 2025, Geron Corporation announced its Q4 2024 financial results, revealing that Rytello's growth had flattened, leading to a 32.07% drop in Geron Corporation's stock price. Investors have until May 12, 2025, to seek appointment as lead plaintiff in these lawsuits, which are filed in the United States — United States District Court for the Northern District of California.

100 Robbins Geller Rudman & Dowd LLP filed class action lawsuit Geron Corporation
90 Levi & Korsinsky notified shareholders of lawsuit Geron Corporation
83 Geron Corporation announced financial results
stock
Geron Corporation is the defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about the launch and growth potential of its drug Rytello, which led to a significant stock price decline.
Importance 100.0 Sentiment -70.0
priv
Robbins Geller Rudman & Dowd LLP is a law firm that has filed a class action lawsuit against Geron Corporation for securities fraud.
Importance 80.0 Sentiment 50.0
oth
Rytello (imetelstat) is the drug developed by Geron Corporation whose sales growth flattened, leading to the alleged misleading statements and subsequent class action lawsuit.
Importance 70.0 Sentiment -30.0
per
Jennifer N. Caringal is an attorney at Robbins Geller Rudman & Dowd LLP, involved in the class action lawsuit against Geron Corporation.
Importance 60.0 Sentiment 50.0
per
J. C. Sanchez is an attorney at Robbins Geller Rudman & Dowd LLP, involved in the class action lawsuit against Geron Corporation.
Importance 60.0 Sentiment 50.0
per
Reza Dabestani is a named plaintiff in one of the class action lawsuits against Geron Corporation.
Importance 10.0 Sentiment 0.0
per
Importance 0.0 Sentiment 0.0
priv
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.